- Home
- ALVR vs TYGO Comparison
ALVR vs TYGO Comparison
Compare ALVR & TYGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALVR
- TYGO
- Stock Information
- Founded
- ALVR 2013
- TYGO 2007
- Country
- ALVR United States
- TYGO United States
- Employees
- ALVR N/A
- TYGO N/A
- Industry
- ALVR Biotechnology: Biological Products (No Diagnostic Substances)
- TYGO Semiconductors
- Sector
- ALVR Health Care
- TYGO Technology
- Exchange
- ALVR Nasdaq
- TYGO Nasdaq
- Market Cap
- ALVR 52.2M
- TYGO 59.8M
- IPO Year
- ALVR 2020
- TYGO N/A
- Fundamental
- Price
- ALVR $0.45
- TYGO $1.00
- Analyst Decision
- ALVR Sell
- TYGO Buy
- Analyst Count
- ALVR 1
- TYGO 3
- Target Price
- ALVR $0.50
- TYGO $3.00
- AVG Volume (30 Days)
- ALVR 325.1K
- TYGO 34.5K
- Earning Date
- ALVR 11-12-2024
- TYGO 02-11-2025
- Dividend Yield
- ALVR N/A
- TYGO N/A
- EPS Growth
- ALVR N/A
- TYGO N/A
- EPS
- ALVR N/A
- TYGO N/A
- Revenue
- ALVR N/A
- TYGO $45,985,000.00
- Revenue This Year
- ALVR N/A
- TYGO N/A
- Revenue Next Year
- ALVR N/A
- TYGO $57.24
- P/E Ratio
- ALVR N/A
- TYGO N/A
- Revenue Growth
- ALVR N/A
- TYGO N/A
- 52 Week Low
- ALVR $0.40
- TYGO $0.78
- 52 Week High
- ALVR $1.05
- TYGO $2.12
- Technical
- Relative Strength Index (RSI)
- ALVR 41.21
- TYGO 54.29
- Support Level
- ALVR $0.42
- TYGO $0.84
- Resistance Level
- ALVR $0.48
- TYGO $1.06
- Average True Range (ATR)
- ALVR 0.04
- TYGO 0.09
- MACD
- ALVR 0.01
- TYGO 0.02
- Stochastic Oscillator
- ALVR 48.98
- TYGO 72.35
About ALVR AlloVir Inc.
AlloVir Inc is a late clinical-stage cell therapy company. The company focuses on developing innovative allogeneic T-cell therapies to combat viral diseases. Their proprietary VST therapy platform enables the creation of off-the-shelf VSTs, addressing the urgent medical need for treating patients with limited viral disease treatment options. With a singular focus on research, development, and commercialization, the company's platform targets 11 devastating viruses, with posoleucel being the lead candidate addressing six viruses. Operating within one segment, the company is dedicated to preventing and treating severe viral-associated diseases through off-the-shelf VST therapies.
About TYGO Tigo Energy Inc.
Tigo Energy Inc designs solar power conversion and storage products that provide customers with more choice and flexibility. Its mission is to deliver smart hardware and software solutions that enhance safety, increase energy yield, and lower operating costs of residential, commercial, and utility-scale solar systems.